Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,109.14
(
-0.24%
)
US TECH 100
25,871.20
(
-0.32%
)
Dow Jones
49,442.56
(
-0.01%
)
Brent Oil
91.18
(
-1.59%
)
Bitcoin
76,285.29
(
3.28%
)
News Focus
News Focus
Post# of 257430
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122879
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: justrpaul post# 186717

Wednesday, 01/28/2015 7:42:22 PM

Wednesday, January 28, 2015 7:42:22 PM

Post# of 257430

8% assumes the entire GT1 ESRX population would be captured, not just the 25% in the exclusive ABBV deal. So, this is quite a stretch.

Huh? 25M is the number of lives insured by clients who use ESRX’s national formulary (not the total number of lives handled by ESRX)—see #msg-110049781.

25M lives is 8% of the US population.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today